2009
DOI: 10.1007/dcr.0b013e31819a235d
|View full text |Cite
|
Sign up to set email alerts
|

Intra-Abdominal Venous and Arterial Thromboembolism in Inflammatory Bowel Disease

Abstract: Venous and arterial thromboembolism constitutes a significant cause of morbidity and mortality in patients with inflammatory bowel disease. The most common thrombotic manifestations are lower extremity deep vein thromboses with or without pulmonary embolism. Occasionally, thromboembolic events occur in the main abdominal vessels, such as the portal and superior mesenteric veins, vena cava and hepatic vein, aorta, splanchnic and iliac arteries, or in the limb arteries. The decision-making process for the treatm… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
23
0

Year Published

2010
2010
2020
2020

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 27 publications
(24 citation statements)
references
References 89 publications
(100 reference statements)
0
23
0
Order By: Relevance
“…Microvascular endothelial dysfunction with diminished vasodilatory capacity causes reduced perfusion, impairs wound healing, and triggers inflammation in IBD (32). Venous and arterial thromboembolism is the major cause of morbidity and mortality in IBD patients (33). Some genetic factors and drugs used in treatment could also promote the pathophysiology of neuronal and vascular damage in IBD (34,35).…”
Section: Discussionmentioning
confidence: 99%
“…Microvascular endothelial dysfunction with diminished vasodilatory capacity causes reduced perfusion, impairs wound healing, and triggers inflammation in IBD (32). Venous and arterial thromboembolism is the major cause of morbidity and mortality in IBD patients (33). Some genetic factors and drugs used in treatment could also promote the pathophysiology of neuronal and vascular damage in IBD (34,35).…”
Section: Discussionmentioning
confidence: 99%
“…In the first episode, 6 months' coverage is recommended, but it is extended if the risk factors have not disappeared (surgery or immobilization), lifelong anticoagulation in patients with an inherited hypercoagulable state. 16 The optimum duration of antibiotic therapy is also unclear, but a prolonged course is suggested on the assumption of difficult penetration of antibiotics into the infected thrombus.…”
Section: Discussionmentioning
confidence: 99%
“…It is plausible that the identification of steroid use as a risk factor is a surrogate marker for an underlying condition such as an autoimmune condition or inflammatory bowel disease that may predispose to thrombosis. 12,13 The category of "bleeding disorder" captures patients who are taking anticoagulants at the time of admission. By definition, this patient population is at increased risk of a future thromboembolic event because of underlying risk factors that precipitated the commencement of anticoagulation and because of the disruption of their anticoagulation regimen.…”
Section: Discussionmentioning
confidence: 99%